Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Ingwiller

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|February 11, 2026
Potassium Levels and Risk of Ventricular ArrhythmiasMaxime Ingwiller
Kidney International|April 20, 2025
Clarifying the interpretation of semaglutide's impact in the FLOW studyMaxime Ingwiller
Clinical Kidney Journal|March 11, 2025
Automated dialysate sodium control system: a word of caution regarding potassiumMaxime Ingwiller
The New England Journal of Medicine|April 23, 2025
APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West AfricansMaxime Ingwiller
Kidney International Reports|August 15, 2025
Optimizing Furosemide Use in Advanced CKD: Balancing Risks and BenefitsThierry Hannedouche, Maxime Ingwiller
Kidney Medicine|June 13, 2025
Response to the letter by ItoMaxime Ingwiller, Thierry Hannedouche
International Urology and Nephrology|July 21, 2021
Effects of high- vs low-dose native vitamin D on albuminuria and the renin-angiotensin-aldosterone system: a randomized pilot studyThierry Krummel, Maxime Ingwiller, Nicolas Keller, et al.
Kidney Medicine|January 31, 2025
Kidney Biopsy-Proven Diabetic and Non-Diabetic Kidney Diseases and Outcomes in Patients With Type 2 Diabetes Receiving Dialysis: The REIN RegistryMaxime Ingwiller, Arnaud Delautre, Jean-Michel Tivollier, et al.
Scientific Reports|November 10, 2024
Diuretics and mortality reduction in incident dialysis patients: a two-year observational studyMaxime Ingwiller, Dogan-Firat Bozman, Nans Florens, et al.
Clinical Kidney Journal|October 18, 2024
Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort studyMaxime Ingwiller, Nicolas Keller, Thierry Krummel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|February 11, 2026
Potassium Levels and Risk of Ventricular ArrhythmiasMaxime Ingwiller
Kidney International|April 20, 2025
Clarifying the interpretation of semaglutide's impact in the FLOW studyMaxime Ingwiller
Clinical Kidney Journal|March 11, 2025
Automated dialysate sodium control system: a word of caution regarding potassiumMaxime Ingwiller
The New England Journal of Medicine|April 23, 2025
APOL1 Bi- and Monoallelic Variants and Chronic Kidney Disease in West AfricansMaxime Ingwiller
Kidney International Reports|August 15, 2025
Optimizing Furosemide Use in Advanced CKD: Balancing Risks and BenefitsThierry Hannedouche, Maxime Ingwiller
Kidney Medicine|June 13, 2025
Response to the letter by ItoMaxime Ingwiller, Thierry Hannedouche
International Urology and Nephrology|July 21, 2021
Effects of high- vs low-dose native vitamin D on albuminuria and the renin-angiotensin-aldosterone system: a randomized pilot studyThierry Krummel, Maxime Ingwiller, Nicolas Keller, et al.
Kidney Medicine|January 31, 2025
Kidney Biopsy-Proven Diabetic and Non-Diabetic Kidney Diseases and Outcomes in Patients With Type 2 Diabetes Receiving Dialysis: The REIN RegistryMaxime Ingwiller, Arnaud Delautre, Jean-Michel Tivollier, et al.
Scientific Reports|November 10, 2024
Diuretics and mortality reduction in incident dialysis patients: a two-year observational studyMaxime Ingwiller, Dogan-Firat Bozman, Nans Florens, et al.
Clinical Kidney Journal|October 18, 2024
Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort studyMaxime Ingwiller, Nicolas Keller, Thierry Krummel, et al.
Pageof 2